Thursday, June 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “GLP-1”

15 pharma patents match "GLP-1" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 15
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 15 pharmaceutical patents matching "GLP-1" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

15 results for “GLP-1” · 30,257 patents in full index Clear search

  1. WO 2025252715

    AGONISTE DOUBLE DU RÉCEPTEUR DU GLP-1 ET DU GLUCAGON POUR LE TRAITEMENT DE LA MASH ET DE LA CIRRHOSE

    BOEHRINGER INGELHEIM INT [DE] · Granted Dec 11, 2025 · Expires Dec 6, 2045

    granted
  2. US 12291530

    GLP-1R agonist and therapeutic method thereof

    Ascletis Pharma (China) Co., Limited · Granted May 6, 2025 · Expires May 1, 2045

    granted
  3. US 12234236

    GLP-1R agonist and therapeutic method thereof

    Ascletis Pharma (China) Co., Limited · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  4. US 12215133

    GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  5. US 12145974

    Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of an immunoglobulin

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  6. US 12115225

    GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof

    Ionis Pharmaceuticals, Inc. · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  7. US 10941187

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted
  8. US 8853160

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  9. US 8580919

    Polymer conjugates of GLP-1

    Nektar Therapeutics · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  10. US 8293869

    Polymer conjugates of GLP-1

    Nektar Therapeutics · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted
  11. US 8278272

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  12. US 7576050

    GLP-1 exendin-4 peptide analogs and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted
  13. US 7276352

    Induction of β cell differentiation in human cells by stimulation of the GLP-1 receptor

    The Regents of the University of California · Granted Oct 2, 2007 · Expires Sep 27, 2027

    granted
  14. US 7056734

    Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof

    The United States of America, as represented by the Department of Health and Human Services, N.I.H. · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  15. US 6884585

    Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor

    The Regents of the University of California · Granted Apr 26, 2005 · Expires Apr 21, 2025

    expired